Global Molecular Diagnostics Market By Product (Instruments, Reagents) By Technology (PCR, Sequencing) to Reach USD 8,020.1 Million by 2020: Grand View Research, Inc

Market Size - $4,476.6 mn in 2013, Market Growth - CAGR of 8.7%, Market Trends - High demand for personalized medicine & genetic testing. View full report with TOC - http://www.grandviewresearch.com/industry-analysis/molecular-diagnostics-market.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Grand View Research

Consumer lifestyle and growing demand for genetic testing expected to drive molecular demand over the next six years

San Francisco, California (PRWEB) June 05, 2014

The global market for molecular diagnostics is expected to reach USD 8,020.1 million by 2020, according to a new study by Grand View Research, Inc. Growing demand for personalized medicine and theranostics, and the subsequent introduction of advanced cancer diagnostic technologies are expected to be key factors driving market growth over the next six years. Moreover, the growing global base of geriatric population and chronic diseases such as cancer, coupled with disease triggering lifestyle habits such as smoking and excessive alcohol consumption will positively impact market growth.

Molecular diagnostic reagent products dominated the overall market, accounting for over 50% of global revenue in 2013. Reagent market revenue is expected to reach USD 4,739.9 million by 2020, growing at a CAGR of 9.9% from 2014 to 2020. High consumption rates of molecular diagnostic reagents and the growing number of research and development initiatives pertaining to the field of molecular diagnostics are two key drivers of this product segment. The point of care end-use market for molecular diagnostics is expected to be the fastest growing product segment, at an estimated CAGR of 13.3% from 2014 to 2020, on account of factors such as the growing demand for point of care diagnostic procedures as an effective diagnostic tool rendering rapid and accurate results and the introduction of government initiatives such as CLIA (Clinical Laboratory Improvement Amendments) waived tests.

The report “Molecular Diagnostics Market Analysis By Product (Instruments, Reagents), By Technology (PCR, In Situ Hybridization, Chips & Microarrays, Mass Spectrometry, Sequencing), By Application (Oncology, Pharmacogenomics, Infectious Disease, Genetic Testing, Neurological Disease, Cardiovascular Disease) And Segment Forecasts to 2020,” is available now to Grand View Research customers at http://www.grandviewresearch.com/industry-analysis/molecular-diagnostics-market.

Request Free Sample of This Report at http://www.grandviewresearch.com/industry-analysis/molecular-diagnostics-market/request.

Further key findings from the study suggest:

  • North America dominated the overall market in terms of revenue share in 2013 at 44.6%. The presence of sophisticated healthcare infrastructure, encouraging government initiatives and high patient awareness levels are some of the drivers of this market. In addition, the presence of enhanced R&D activities in the U.S. pertaining to advanced diagnostic technologies attributes to its large market share.
  • The Asia Pacific molecular diagnostics market is expected to grow at the fastest rate of 12.7% from 2014 to 2020. High unmet medical needs in disease segments such as cancer, diabetes and cardiovascular diseases and the introduction of healthcare reforms in emerging markets such as India and China are some of the factors driving regional market growth.
  • PCR based molecular diagnostic technology market revenue was estimated to be USD 2,144.3 million in 2013 and is expected to dominate the market over the next six years. Growing demand for genetic testing as an effective tool to develop personalized medicine based products is one of the most significant growth drivers of this market.
  • Oncology applications dominated the overall market in 2013, accounting for over 30% of total revenue. Unmet medical needs, high global prevalence rates of cancer and the introduction of advanced cancer diagnostic technologies such as companion diagnostics are some of the factors accounting for its large market share.
  • Some of the key players of this market include Roche Diagnostics, Novartis, Qiagen, bioMerieux, Cepheid, Siemens Healthcare, Hologic, Becton Dickinson and Company, Abbott Laboratories and others.

Browse All Biotechnology Market Reports Available at Grand View Research at http://www.grandviewresearch.com/industry/biotechnology.

For the purpose of this study, Grand View Research has segmented the global molecular diagnostics market on the basis of product and region:

  •      Molecular Diagnostics Market Product Outlook
            • Instruments
            • Reagents
            • Others
  •      Molecular Diagnostics Market Technology Outlook
            • PCR
            • In Situ Hybridization
            • Chips and Microarrays
            • Mass Spectrometry
            • Sequencing
            • Others
  •      Molecular Diagnostics Market Application Outlook
            • Oncology
            • Pharmacogenomics
            • Infectious Disease
            • Genetic Testing
            • Neurological Disease
            • Cardiovascular Disease
            • Others
  •      Molecular Diagnostics Market End-User Outlook
            • Point of Care
            • Self Test or OTC
            • Hospitals and Clinics
  •      Molecular Diagnostics Market Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • Rest of the World (RoW)

Browse Grand View Research Ongoing Reports at http://www.grandviewresearch.com/ongoing-reports.

Latest Report By Grand View Research:

Commercial Seeds (Conventional, Biotechnology) Market Analysis By Product (Soybean, Corn, Cotton, Rice) And Segment Forecasts To 2020 (http://www.grandviewresearch.com/industry-analysis/commercial-seeds-market)

The global market for commercial seeds is expected to reach USD 72.09 billion by 2020, according to a new study by Grand View Research, Inc. Growing population coupled with reduction in arable land is expected to boost the demand for GM/bioseeds which are superior to conventional seeds in terms of disease resistance and yield. However, in spite of the advantages offered by GM seeds, the market faces considerable restraint in the form of government regulations in certain countries against the use of GM seeds Corn/maize was the largest consumed commercial seed, accounting for USD 20.07 billion of revenue in 2013.

About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit http://www.grandviewresearch.com/

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519